Cargando…

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma

BACKGROUND: Matrix metallopeptidase 14 (MMP14) is an important gene in the regulation of T-cell function. However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear. METHODS: We investigated the influence of MMP...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Chengliang, Zhang, Junyan, Shen, Ming, Gu, Zhenyang, Li, Yan, Xue, Wanguo, Shi, Jinlong, Huang, Wenrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473157/
https://www.ncbi.nlm.nih.gov/pubmed/32974187
http://dx.doi.org/10.3389/fonc.2020.01520
_version_ 1783579129128419328
author Yin, Chengliang
Zhang, Junyan
Shen, Ming
Gu, Zhenyang
Li, Yan
Xue, Wanguo
Shi, Jinlong
Huang, Wenrong
author_facet Yin, Chengliang
Zhang, Junyan
Shen, Ming
Gu, Zhenyang
Li, Yan
Xue, Wanguo
Shi, Jinlong
Huang, Wenrong
author_sort Yin, Chengliang
collection PubMed
description BACKGROUND: Matrix metallopeptidase 14 (MMP14) is an important gene in the regulation of T-cell function. However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear. METHODS: We investigated the influence of MMP14 on clinical prognosis using data obtained from three Gene Expression Omnibus (GEO) database sets (GSE98588, GSE10846, and GSE4475). The expression of MMP14 was analyzed using the Gene Expression Profiling Interactive Analysis (GEPIA). The correlation between MMP14 and immune cell infiltration was investigated using the Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) and Tumor Immune Estimation Resource (TIMER) tools. In addition, the correlation between MMP14 expression and immune gene markers was analyzed by TIMER and GEPIA. RESULTS: MMP14 expression positively correlated with favorable progression-free survival (PFS; GSE98588, P = 0.02) and overall survival (OS; GSE98588, P = 0.003; GSE10846, P = 5.517e-05; and GSE4475, P = 9.85e-04). Moreover, MMP14 expression was higher in DLBCL tumors than in normal tissues. Regarding clinical characteristics, high MMP14 expression was found to be correlated with race. MMP14 expression was also correlated with immune cell infiltration and had a remarkable correlation with various immune marker sets. It was found that M0 macrophages were the immune cells most related to survival, decreasing with the increase in Ann Arbor clinical stage. The results especially showed that MMP14 was a prognostic biomarker and related to the macrophages M0. CONCLUSION: The results suggest that MMP14 is a novel prognostic molecular marker for DLBCL and is related to the immune cell infiltration, especially related to the macrophages M0. Our study provides insights for understanding the potential roles of MMP14 in tumor immunology and its suitability as a prognosis biomarker in DLBCL.
format Online
Article
Text
id pubmed-7473157
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74731572020-09-23 Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Yin, Chengliang Zhang, Junyan Shen, Ming Gu, Zhenyang Li, Yan Xue, Wanguo Shi, Jinlong Huang, Wenrong Front Oncol Oncology BACKGROUND: Matrix metallopeptidase 14 (MMP14) is an important gene in the regulation of T-cell function. However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear. METHODS: We investigated the influence of MMP14 on clinical prognosis using data obtained from three Gene Expression Omnibus (GEO) database sets (GSE98588, GSE10846, and GSE4475). The expression of MMP14 was analyzed using the Gene Expression Profiling Interactive Analysis (GEPIA). The correlation between MMP14 and immune cell infiltration was investigated using the Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) and Tumor Immune Estimation Resource (TIMER) tools. In addition, the correlation between MMP14 expression and immune gene markers was analyzed by TIMER and GEPIA. RESULTS: MMP14 expression positively correlated with favorable progression-free survival (PFS; GSE98588, P = 0.02) and overall survival (OS; GSE98588, P = 0.003; GSE10846, P = 5.517e-05; and GSE4475, P = 9.85e-04). Moreover, MMP14 expression was higher in DLBCL tumors than in normal tissues. Regarding clinical characteristics, high MMP14 expression was found to be correlated with race. MMP14 expression was also correlated with immune cell infiltration and had a remarkable correlation with various immune marker sets. It was found that M0 macrophages were the immune cells most related to survival, decreasing with the increase in Ann Arbor clinical stage. The results especially showed that MMP14 was a prognostic biomarker and related to the macrophages M0. CONCLUSION: The results suggest that MMP14 is a novel prognostic molecular marker for DLBCL and is related to the immune cell infiltration, especially related to the macrophages M0. Our study provides insights for understanding the potential roles of MMP14 in tumor immunology and its suitability as a prognosis biomarker in DLBCL. Frontiers Media S.A. 2020-08-20 /pmc/articles/PMC7473157/ /pubmed/32974187 http://dx.doi.org/10.3389/fonc.2020.01520 Text en Copyright © 2020 Yin, Zhang, Shen, Gu, Li, Xue, Shi and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yin, Chengliang
Zhang, Junyan
Shen, Ming
Gu, Zhenyang
Li, Yan
Xue, Wanguo
Shi, Jinlong
Huang, Wenrong
Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
title Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
title_full Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
title_fullStr Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
title_full_unstemmed Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
title_short Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
title_sort matrix metallopeptidase 14: a candidate prognostic biomarker for diffuse large b-cell lymphoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473157/
https://www.ncbi.nlm.nih.gov/pubmed/32974187
http://dx.doi.org/10.3389/fonc.2020.01520
work_keys_str_mv AT yinchengliang matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT zhangjunyan matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT shenming matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT guzhenyang matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT liyan matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT xuewanguo matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT shijinlong matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma
AT huangwenrong matrixmetallopeptidase14acandidateprognosticbiomarkerfordiffuselargebcelllymphoma